Schiff advised Altaris Capital Partners, LLC on its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc, for $1.55 billion.
Last week the Supreme Court agreed to hear the case Unicolors, Inc. v. H & M Hennes & Mauritz, LP, which considers when inaccuracies in a US copyright application can be used to invalidate a resulting registration.
As we enter the COVID-19 vaccine roll-out era, there are still many questions surrounding the healthcare workplace.
Hospitals, healthcare centers, senior living facilities, and long-term care facilities all have unique issues and challenges relating to the needs and safety of employees, patients, a
In this installment of Arent Fox’s Cannabis Counsel Cast, Partners Emily M. Leongini and Lynn R. Fiorentino discuss a recent proposal to require new Prop 65 warnings for cannabis products that expose consumers to THC and/or “marijuana smoke.”
As we previously reported, in 2019 the California Chamber of Commerce filed suit against the State of California requesting that the State and private enforcers be enjoined from requiring Proposition 65 warnings on foods that contain acrylamide. Since then, manufacturers and distributors of ce
In an attempt to align with their clients’ values, fashion companies have tried to manufacture and produce clothing that is ethically made and sustainable.
Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in its agreement to acquire Perrigo Company plc’s prescription pharmaceuticals business (Rx) for $1.55 billion.
On January 8, 2021, the agency governing Proposition 65, the California Office of Environmental Health Hazard Assessment (OEHHA) proposed to amend the content and conditions for use associated with the widely-used short-form warning permitted under Proposition 65.
Arent Fox is pleased to announce the expansion of its International Trade & Investment practice with the addition of customs and trade law Partner Angela M. Santos in the firm’s New York office.
Join Arent Fox Partner Lynn Fiorentino at the American Conference Institute’s 8th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products (virtual event).
In our first Cannabis Counsel Cast episode, Partners Emily Leongini and Lynn Fiorentino discuss the potential impact of California’s Prop. 65 on manufacturers, distributors, and sellers of cannabis products, particularly in light of the January 4, 2021 enforcement date for new THC and marijuana smok
On September 30, 2020, California Governor Gavin Newsom signed two pieces of legislation that place dramatic restrictions on companies selling cosmetics and personal care products in California.
